The end use of this project proposal is to provide evidence for the attribution of a therapeutic property to the dietary supplement tryptophan (Trp) for pathological fatigue in patients with inflammatory bowel disease (IBD) in remission. It offers gastroenterologists and general practitioners the opportunity to treat this persistent complaint in their patient population, through a means that is widely available and safe.